NeuroAiD™II has been awarded Gold accreditation by
independent nonprofit Empowered By Evidence (EBE)
Bringing Innovative Solutions to Healthcare Practitioners
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries Of The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Shaping the Future of Neurological Care
David Picard, CEO of Moleac, shares insights on unmet needs in post-stroke care and the role of science in improving outcomes for neurological conditions.
Latest News
Driving Collaboration in Brain Injury Care: Neurovascular Summit Highlights from Taipei
Unlocking Recovery Potential: Join Our ESOC 2026 Symposium on Post-Stroke Neurorehabilitation
Can Homocysteine Track Alzheimer’s Progression? New Insights into a Promising Biomarker
Protecting Nature, Protecting Brain Health: An Earth Day Reminder
Protecting the planet is protecting our health.
Advancing Neurological Recovery: Highlights from Moleac’s Marrakesh Scientific Meeting
Last week, Moleac hosted a meeting in Marrakesh, Morocco, focused on advancing care for neurological disorders.
Moleac at ESOC 2026: Advancing Stroke Care Together
We are pleased to announce our participation at the European Stroke Organisation Conference (ESOC), taking place from 6–8 May 2026 in Maastricht, Netherlands.
Strengthening Partnerships: Highlights from Moleac’s Europe Affiliates Convention 2026
The Gut-Brain Connection: Understanding Gastrointestinal Dysfunction After TBI
Making a Difference: Our Continued Partnership with the Kythe Foundation
Innovation and Insights: Highlights from our Scientific Meeting in Larnaca
In February, Moleac held the NeuroAiD and Alzheimer’s Disease Scientific Meeting in Larnaca (Cyprus).
